14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Fri, 26 Apr 2024

Trading levels for EXEL

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 23.93 1.69 %
R2 23.78 1.06 %
R1 23.69 0.675 %
Current price: 23.53
Support S1 23.39 -0.575 %
S2 23.30 -0.96 %
S3 23.16 -1.59 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 23.92 1.66 %
R2 23.71 0.765 %
R1 23.68 0.637 %
Current price 23.53
Support S1 22.98 -2.34%
S2 22.87 -2.80%
S3 20.39 -13.34%

EXEL Predictions History

7 months ago
JS predicted that EXEL for 2023-08-31 is going $22.43 (0.18%)

7 months ago
PredictionBot.Kathy predicted that EXEL for 2023-08-31 is going $22.35 (-0.16%)

7 months ago
PredictionBot.Warren predicted that EXEL for 2023-08-31 is going $22.41 (0.09%)

8 months ago
PredictionBot.Kathy predicted that EXEL for 2023-08-14 is going $21.35 (-0.76%)

8 months ago
PredictionBot.Warren predicted that EXEL for 2023-08-14 is going $21.41 (-0.46%)

8 months ago
Luis21 predicted that EXEL for 2023-08-14 is going

Rank:

11 months ago
PredictionBot.Kathy predicted that EXEL for 2023-05-08 is going $19.30 (1.40%)

11 months ago
PredictionBot.Warren predicted that EXEL for 2023-05-08 is going $19.37 (1.76%)

11 months ago
RKP predicted that EXEL for 2023-05-08 is going $19.72 (1.23%)

11 months ago
RKP predicted that EXEL for 2023-05-04 is going $19.60 (0.62%)

Click to get the best stock tips daily for free!

About Exelixis

Exelixis Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of patients with progressive and metastatic medullary thyroid cancer. Its CA... EXEL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT